Back


06/07/2018
Dynacure secures €47 million financing to advance lead program into clinical development
Financing will support clinical development of lead antisense oligonucleotide candidate for centronuclear myopathy (CNM), and additional preclinical research programs for other orphan disorders [...]

Download the pdf file





X

X